Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
83.67
-3.49 (-4.00%)
At close: Apr 28, 2026, 4:00 PM EDT
84.00
+0.33 (0.39%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Dianthus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4,556 | 1,767 | 645 | 154 | - | - |
| Market Cap Growth | 809.03% | 173.85% | 318.69% | - | - | - |
| Enterprise Value | 4,043 | 1,213 | 364 | -35 | - | - |
| Last Close Price | 83.67 | 41.21 | 21.80 | 10.40 | - | - |
| PS Ratio | 2237.59 | 867.84 | 103.48 | 54.53 | - | - |
| PB Ratio | 7.33 | 3.58 | 1.83 | 0.91 | - | - |
| P/TBV Ratio | 9.23 | 3.58 | 1.83 | 0.91 | - | - |
| EV/Sales Ratio | 1985.60 | 595.64 | 58.45 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | - |
| Net Debt / Equity Ratio | -1.04 | -1.04 | -1.01 | -1.02 | -1.01 | -1.86 |
| Net Debt / EBITDA Ratio | 2.89 | 2.89 | 3.49 | 3.60 | 2.52 | - |
| Net Debt / FCF Ratio | 3.97 | 3.97 | 4.54 | 4.68 | 2.56 | 0.77 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.02 | 0.14 | - |
| Quick Ratio | 13.16 | 13.16 | 14.96 | 18.09 | 9.86 | 1.70 |
| Current Ratio | 13.32 | 13.32 | 15.22 | 18.43 | 9.97 | 1.75 |
| Return on Equity (ROE) | -38.38% | -38.38% | -32.60% | -35.92% | -73.25% | - |
| Return on Assets (ROA) | -24.58% | -24.58% | -23.01% | -22.94% | -40.12% | - |
| Return on Capital Employed (ROCE) | -35.60% | -35.60% | -28.60% | -28.40% | -39.70% | -319.20% |
| Earnings Yield | -3.56% | -9.19% | -13.17% | -28.26% | - | - |
| FCF Yield | -2.84% | -7.32% | -12.13% | -23.99% | - | - |
| Buyback Yield / Dilution | -15.92% | -15.92% | -546.44% | -489.48% | 78.17% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.